Our annual trend report for the Dutch life sciences market shows that the country remains an important centre of the industry. There were 14 major financing rounds in the biotech sector in 2016 for the total amount of 71 million USD. However, the number of newly founded companies was much lower in 2016 than in the previous years. According to our data, there are almost 500 biotech and around 120 medtech companies in The Netherlands at the moment. For the first time, we included the healthtech sector in our analysis as it grew significantly in recent years.
Please click on the link below for the full report.
Looking for your next Biotech or Medtech partner?
Use Biotechgate to identify new leads, licensing opportunities and management details.